SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-077276
Filing Date
2021-06-07
Accepted
2021-06-07 06:01:18
Documents
14
Period of Report
2021-06-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2118381d2_8k.htm   iXBRL 8-K 30210
2 EXHIBIT 99.1 tm2118381d2_ex99-1.htm EX-99.1 12275
3 GRAPHIC tm2118381d2_ex99-1img001.jpg GRAPHIC 2870
  Complete submission text file 0001104659-21-077276.txt   223565

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA uthr-20210607.xsd EX-101.SCH 3184
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE uthr-20210607_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE uthr-20210607_pre.xml EX-101.PRE 22709
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2118381d2_8k_htm.xml XML 3504
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26301 | Film No.: 21998111
SIC: 2834 Pharmaceutical Preparations